Pasithea Therapeutics Corp. /
AlloMek Therapeutics, LLC
Pasithea Therapeutics adds AlloMek Therapeutics to its business
- Terms
- Not stated
- Stage
- Closed
What happened
Pasithea Therapeutics Corp. completed its acquisition of AlloMek Therapeutics, LLC on Oct. 11, 2022, purchasing all of the company’s issued and outstanding equity.
The consideration included common stock, warrants and a cash payment, along with potential milestone and earn-out payments.
The source
Everything on this page comes from the source below.
Pasithea Therapeutics adds AlloMek Therapeutics to its business
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Closed
The source this page is built from.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly